News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Longwood Fund II, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/10/2022 |
SC 13D/A
| Longwood Fund II, L.P. reports a 0% stake in KalVista Pharmaceuticals, Inc. |
| 10/26/2018 |
SC 13D/A
| Longwood Fund II, L.P. reports a 21.8% stake in Flex Pharma, Inc. |
| 10/18/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/20/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 05/19/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/22/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/15/2016 |
4
| Longwood Fund II, L.P. (10% Owner) has filed a Form 4 on Flex Pharma, Inc.|
Txns:
| Bought 89,680 shares
@ $7, valued at
$627.8k
|
|
| 02/19/2015 |
SC 13D
| Longwood Fund II, L.P. reports a 37% stake in Flex Pharma, Inc. |
| 02/13/2015 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
| 02/04/2015 |
4
| Longwood Fund II, L.P. (10% Owner) has filed a Form 4 on Flex Pharma, Inc.|
Txns:
| Converted 1,868,067 shares
@ $0
Converted 516,697 shares
@ $0
Converted 8,000,000 preferred shares
@ $0
Converted 2,212,756 preferred shares
@ $0 |
|
| 11/06/2012 |
D
| Form D - Notice of Exempt Offering of Securities |
|
|